Lipoprotein (a) levels in normal pregnancy and in pregnancy complicated with pre-eclampsia

Atherosclerosis

Volumn 148, Issue 2, 2000, Pages 407-411

  Sattar, Naveed ^b   Clark, Peter ^a   Greer, Ian A ^c   Shepherd, James ^b   Packard, Chris J ^b  

^a 3rd Fl Macewen Bldg Roy I ^*  (United Kingdom)

^b NHS Greater Glasgow and Clyde Clinical Biochemistry Service   (United Kingdom)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Lipoprotein (a); Pre eclampsia; Pregnancy

Indexed keywords

CHOLESTEROL; LIPOPROTEIN A; PLASMINOGEN; TRIACYLGLYCEROL;

ADULT; ARTERY THROMBOSIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; GESTATIONAL AGE; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; VEIN THROMBOSIS;

ADULT; FEMALE; HUMANS; LIPOPROTEIN(A); OSMOLAR CONCENTRATION; PRE-ECLAMPSIA; PREGNANCY; REFERENCE VALUES;

EID: 0033964874     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00296-8     Document Type: Article

References (34)

1. Berg K. A new serum type system in man. Acta Pathol. Microbiol. Scand. 59:1963;369-392.
2. Lindahl G., Gersdorf W., Menzel H.J. et al. The gene for the Lp(a)-specific glycoprotein is closely linked to the gene for plasminogen on chromosome 6. Hum. Genet. 81:1989;149-152.
3. Utermann G., Menzel H.J., Kraft H.G., Duba H.C., Kemmler H.G., Seitz C. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J. Clin. Invest. 80:1987;458-465.
4. Maeda S., Abe A., Seishima M., Makino K., Norma A., Kawade M. Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis. 78:1989;145-150.
5. Leren T.P., Hjermann I., Berg K., Leren P., Fodd O.P., Viksmoen L. Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia. Atherosclerosis. 73:1988;135-141.
6. Kostner G.M., Gavish D., Leopold K., Bolzano K., Weintraub M.S., Breslow J.L. HMGCoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels. Circulation. 80:1989;1313-1319.
7. Mosca L., Bowlin S., Davidson L., Jenkins P., Pearson T.A. Estrogen replacement therapy and lipoprotein (a). Circulation. 84:1991;546A.
8. Soma M., Fumagalli R., Paoletti R. et al. Plasma Lp(a) concentration after oestrogen and progestogen in postmenopausal women (letter). Lancet. 337:1991;612.
9. Dahlen G.H., Guyton J.R., Attar M., Farmer J.A., Kautz J.A., Gotto A.M. Association of levels of lipoprotein(a), plasma lipids and other lipoproteins with coronary artery disease documented by angiography. Circulation. 74:1986;758-765.
10. Scott J. Lipoprotein(a). Br. Med. J. 303:1991;663-664.
11. Yamazaki M., Asakura H., Jokaji H. et al. Plasma levels of lipoprotein(a) are elevated in patients with the antiphospholipid antibody syndrome. Thromb. Haemost. 71:1994;424-427.
12. Bandello F., Vigano D.A.S., Parlavecchia M. et al. Hypercoagulability and high lipoprotein(a) levels in patients with central retinal vein occlusion. Thromb. Haemost. 72:1994;39-43.
13. Miles L.A., Fless G.M., Levin E.G., Scanu A.M., Plow E.F. A potential basis for the thrombotic risk associated with lipoprotein (a). Nature. 339:1989;301-303.
14. Etingin O.R., Hajjar D.P., Hajjar K.A., Harpel P.C., Nachman R.L. J. Biol. Chem. 266:1991;2459-2465.
15. Hajjar K.A., Gavish D., Breslow J.L., Nachman R.L. Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atheroslcerosis. Nature. 339:1989;303-305.
16. Harpel P.C., Gordon B.R., Parker T.S. Plasmin catalyses binding of lipoprotein (a) to immobilized fibrinogen and fibrin. Proc. Natl. Acad. Sci. USA. 86:1989;3847-3851.
17. Greer I.A. Haemostasis and thrombosis in pregnancy. Bloom A.L., Forbes C.D., Thomas D.P., Tuddenham E.G.D. Haemostasis and Thrombosis. 1994;987-1015 Butterworths, London.
18. Wang J., Mimuro S., lahoud R., Trudinger B., Wang X.L. Elevated levels of lipoprotein(a) in women with pre-eclampsia. Am. J. Obstet. Gynecol. 178:1998;146-149.
19. Cahcia O., Leger C.L., Boulot P., Vernet M.H., Michel F., Crastes de Paulet A., Descomps B. Red blood cell vitamin E concentration in fetuses are related to but lower than those in mothers during gestation. A possible association with maternal lipoprotein(a) plasma levels. Am. J. Obstet. Gynecol. 173:1995;42-51.
20. Zechner R., Desoye G., Schweditsch M.O., Pfeiffer K.P., Kostner G.M. Fluctuations of plasma lipoprotein-A concentrations during pregnancy and post partum. Metabolism. 35:1986;333-336.
21. Neary R.H., Kilby M.D., Kumpatula P., Game F.L., Bhatnagar D., Durrington P.N., O'Brien P.M. Fetal and maternal lipoprotien metabolsim in human pregnancy. Clin. Sci. 88:1995;311-318.
22. Bonnar J., Daly L., Sheppard B.L. Changes in the fibrinolytic system during pregnancy. Semin. Thromb. Haemost. 16:1990;221-229.
23. Schjetlein R., Haugen G., Wisloff F. Markers of intravascular coagulation and fibrinolysis in preeclampsia: association with intrauterine growth retardation. Acta Obstet. Gynecol. Scand. 76:1997;541-546.
24. Sattar N., Bendomir A., Berry C., Shepherd J., Greer I.A., Packhard C.J. Lipoprotein subfraction concentrations in pre-eclampsia: pathogenic parallels to atherosclerosis. Obstet. Gynecol. 89:1997;403-408.
25. Labarrere C.A. Acute atherosis. A histopathological hallmark of immune aggression. Placenta. 9:1988;95-108.
26. Meekins J.W., Pijnenborg R., Hanssens M., van Assche A., McFadyen I.R. Immunohistochemical detection of lipoprotein (a) in the wall of placental bed spiral arteries in normal and severe-pre-eclamptic pregnancies. Placenta. 15:1994;511-524.
27. Berg K., Roald B., Sande H. High Lp(a) lipoprotein level in maternal serum may interfere with placental circulation and cause fetal growth retardation. Clin. Genet. 46:1994;52-56.
28. Sattar N., Greer I.A., Loudon J., Lindsay G., Mcconnell M., Shepherd J., Packard C.J. Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, low density lipoprotein. J. Clin. End. Metab. 82:1997;2483-2491.
29. Gaw A., Gourlay C.W., Brown E.A., Bell A. Evaluation of a new automated latex agglutination assay for lipoprotein(a): comparison with manual ELISA. Clin. Chim. Acta. 261:1997;175-183.
30. Lipid Research Clinics Program. Manual of Laboratory Operations. Lipid and Lipoprotein Analysis. National Institute of Health. Bethseda, MD: DHEW Publications (NIH), 1975, p. 75.
31. Pekelharing H.L., Aalders N.L., Visser G.H. et al. Method-dependent increase in lipoprotein(a) in insulin-dependent diabetes mellitus during pregnancy. Metabolism. 44:1995;1606-1611.
32. Paidas M.J., Kuczynski E., Salafia C., Lockwood C.J. Plasma levels of lipoprotein(a) are not elevated in women destined to develop pre-eclampsia. J. Soc. Gynecol. Invest. 6(Suppl.):1999;124A.
33. Potter J.M., Nestel P.J. The hyperlipidaemia of pregnancy in normal and complicated pregnancies. Am. J. Obstet. Gynecol. 133:1979;165-170.
34. Hubel C.A., Mclaughlin M.K., Evans R.W., Hauth B.A., Sims C.J., Riberts J.M. Fasting triglycerides, free fatty acids and malondiadehyde are increased in pre-eclampsia are positively correlated, and decrease within 48 hours post-partum. Am. J. Obstet. Gynecol. 174:1996;975-982.